User is not a member of any group.
There are currently 0 users online.
A landmark programme to test potential COVID-19 therapies in dozens of countries is restarting with a fresh roster of treatments — this time aimed at tempering the raging immune responses that can worsen severe disease.
Summary box
Recent Comments